tiprankstipranks

Timothy Scannell Insider Profile

4 Followers
Timothy Scannell, Director at NovoCure, holds 25.90K shares in NovoCure (Ticker: NVCR), holds ― shares in Molekule Group (Ticker: MKULQ), holds 0.00 shares in Masimo (Ticker: MASI).
tipranks
Timothy Scannell

Timothy Scannell
NovoCure (NVCR)
Director

Ranked #95,096 out of 108,921 Corporate Insiders

Profitable Transactions

35%
6 out of 17 Profitable Transactions

Average Return

-16.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$74M
92.75%
6.62%
0.63%
A breakdown of Timothy Scannell's holdings

Insider Roles

Stryker
(SYK)
President & COO
Insulet
(PODD)
Director
NovoCure
(NVCR)
Director
Roles that Timothy Scannell holds in companies

Most Profitable Insider Trade

Stock:
NovoCure
(NVCR)
Rating:Informative Sell
Date:Jun 06, 2024 - Jun 06, 2025
Return:+23.20%
The most profitable trade made by Timothy Scannell

Timothy Scannell's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
NovoCure
Jun 05, 2026
Director
Uninformative Buy
$464.61K
MKULQ
Molekule Group
EXAS
Exact Sciences
Nov 01, 2023
Uninformative Buy
$597.36K
MASI
Masimo
Jun 12, 2026
Uninformative Sell
469.44K
$0.00
Stryker
Aug 03, 2021
President & COO
Uninformative Buy
484.17K
$68.27M
Insulet
May 21, 2026
Director
Uninformative Buy
$4.87M
List of latest transactions for each holding click on a transaction to see Timothy Scannell's performance on stock

Timothy Scannell insider profile FAQ

What is the percentage of profitable transactions made by Timothy Scannell?
The percentage of profitable transactions made by Timothy Scannell is 35%.
    What is the average return per transaction made by Timothy Scannell?
    The average return per transaction made by Timothy Scannell is -16.50%.
      What stocks does Timothy Scannell hold?
      Timothy Scannell holds: NVCR, MKULQ, EXAS, MASI, SYK, PODD stocks.
        What was Timothy Scannell’s latest transaction?
        Timothy Scannell latest transaction was an Uninformative Buy of ―.
          What was Timothy Scannell's most profitable transaction?
          Timothy Scannell’s most profitable transaction was an Informative Sell of NVCR stock on June 6, 2024. The return on the trade was 23.20%.
            What is Timothy Scannell's role in NovoCure?
            Timothy Scannell's role in NovoCure is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.